ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lurasidone Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-25E8216
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and Japan Lurasidone Market Insights Forecast to 2027
BUY CHAPTERS

Global Lurasidone Market Research Report 2024

Code: QYRE-Auto-25E8216
Report
February 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co Ltd
Remedyrepack
Bushu Pharmaceutical, LTD.
Zhejiang Hisun Pharmaceutical Co Ltd
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.

Lurasidone Market

Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.
The global Lurasidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
This report aims to provide a comprehensive presentation of the global market for Lurasidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lurasidone.

Report Scope

The Lurasidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lurasidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lurasidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lurasidone Market Report

Report Metric Details
Report Name Lurasidone Market
Segment by Type
  • 20mg/tablet
  • 40mg/tablet
  • 60mg/tablet
  • 80mg/tablet
  • 120mg/tablet
Segment by Application
  • Hospital
  • Psychological Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Angelini Holding S.p.A., Sumitomo Dainippon Pharma Co., Ltd., RemedyRepack，Inc., Bushu Pharmaceutical, LTD., Zhejiang Hisun Pharmaceutical Co., Ltd., Healthcare Pharmaceuticals Limited, Square Pharmaceuticals Ltd., Incepta Pharmaceuticals Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lurasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lurasidone Market report?

Ans: The main players in the Lurasidone Market are Angelini Holding S.p.A., Sumitomo Dainippon Pharma Co., Ltd., RemedyRepack，Inc., Bushu Pharmaceutical, LTD., Zhejiang Hisun Pharmaceutical Co., Ltd., Healthcare Pharmaceuticals Limited, Square Pharmaceuticals Ltd., Incepta Pharmaceuticals Ltd.

What are the Application segmentation covered in the Lurasidone Market report?

Ans: The Applications covered in the Lurasidone Market report are Hospital, Psychological Clinic, Others

What are the Type segmentation covered in the Lurasidone Market report?

Ans: The Types covered in the Lurasidone Market report are 20mg/tablet, 40mg/tablet, 60mg/tablet, 80mg/tablet, 120mg/tablet

1 Lurasidone Market Overview
1.1 Product Overview and Scope of Lurasidone
1.2 Lurasidone Segment by Type
1.2.1 Global Lurasidone Market Value Comparison by Type (2024-2030)
1.2.2 20mg/tablet
1.2.3 40mg/tablet
1.2.4 60mg/tablet
1.2.5 80mg/tablet
1.2.6 120mg/tablet
1.3 Lurasidone Segment by Application
1.3.1 Global Lurasidone Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Psychological Clinic
1.3.4 Others
1.4 Global Lurasidone Market Size Estimates and Forecasts
1.4.1 Global Lurasidone Revenue 2019-2030
1.4.2 Global Lurasidone Sales 2019-2030
1.4.3 Global Lurasidone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lurasidone Market Competition by Manufacturers
2.1 Global Lurasidone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lurasidone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lurasidone Average Price by Manufacturers (2019-2024)
2.4 Global Lurasidone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lurasidone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lurasidone, Product Type & Application
2.7 Lurasidone Market Competitive Situation and Trends
2.7.1 Lurasidone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lurasidone Players Market Share by Revenue
2.7.3 Global Lurasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lurasidone Retrospective Market Scenario by Region
3.1 Global Lurasidone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lurasidone Global Lurasidone Sales by Region: 2019-2030
3.2.1 Global Lurasidone Sales by Region: 2019-2024
3.2.2 Global Lurasidone Sales by Region: 2025-2030
3.3 Global Lurasidone Global Lurasidone Revenue by Region: 2019-2030
3.3.1 Global Lurasidone Revenue by Region: 2019-2024
3.3.2 Global Lurasidone Revenue by Region: 2025-2030
3.4 North America Lurasidone Market Facts & Figures by Country
3.4.1 North America Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lurasidone Sales by Country (2019-2030)
3.4.3 North America Lurasidone Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lurasidone Market Facts & Figures by Country
3.5.1 Europe Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lurasidone Sales by Country (2019-2030)
3.5.3 Europe Lurasidone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lurasidone Market Facts & Figures by Country
3.6.1 Asia Pacific Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lurasidone Sales by Country (2019-2030)
3.6.3 Asia Pacific Lurasidone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lurasidone Market Facts & Figures by Country
3.7.1 Latin America Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lurasidone Sales by Country (2019-2030)
3.7.3 Latin America Lurasidone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lurasidone Market Facts & Figures by Country
3.8.1 Middle East and Africa Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lurasidone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lurasidone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lurasidone Sales by Type (2019-2030)
4.1.1 Global Lurasidone Sales by Type (2019-2024)
4.1.2 Global Lurasidone Sales by Type (2025-2030)
4.1.3 Global Lurasidone Sales Market Share by Type (2019-2030)
4.2 Global Lurasidone Revenue by Type (2019-2030)
4.2.1 Global Lurasidone Revenue by Type (2019-2024)
4.2.2 Global Lurasidone Revenue by Type (2025-2030)
4.2.3 Global Lurasidone Revenue Market Share by Type (2019-2030)
4.3 Global Lurasidone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lurasidone Sales by Application (2019-2030)
5.1.1 Global Lurasidone Sales by Application (2019-2024)
5.1.2 Global Lurasidone Sales by Application (2025-2030)
5.1.3 Global Lurasidone Sales Market Share by Application (2019-2030)
5.2 Global Lurasidone Revenue by Application (2019-2030)
5.2.1 Global Lurasidone Revenue by Application (2019-2024)
5.2.2 Global Lurasidone Revenue by Application (2025-2030)
5.2.3 Global Lurasidone Revenue Market Share by Application (2019-2030)
5.3 Global Lurasidone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Angelini Holding S.p.A.
6.1.1 Angelini Holding S.p.A. Corporation Information
6.1.2 Angelini Holding S.p.A. Description and Business Overview
6.1.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
6.1.5 Angelini Holding S.p.A. Recent Developments/Updates
6.2 Sumitomo Dainippon Pharma Co., Ltd.
6.2.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
6.2.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
6.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
6.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments/Updates
6.3 RemedyRepack，Inc.
6.3.1 RemedyRepack，Inc. Corporation Information
6.3.2 RemedyRepack，Inc. Description and Business Overview
6.3.3 RemedyRepack，Inc. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 RemedyRepack，Inc. Lurasidone Product Portfolio
6.3.5 RemedyRepack，Inc. Recent Developments/Updates
6.4 Bushu Pharmaceutical, LTD.
6.4.1 Bushu Pharmaceutical, LTD. Corporation Information
6.4.2 Bushu Pharmaceutical, LTD. Description and Business Overview
6.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
6.4.5 Bushu Pharmaceutical, LTD. Recent Developments/Updates
6.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
6.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
6.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Healthcare Pharmaceuticals Limited
6.6.1 Healthcare Pharmaceuticals Limited Corporation Information
6.6.2 Healthcare Pharmaceuticals Limited Description and Business Overview
6.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
6.6.5 Healthcare Pharmaceuticals Limited Recent Developments/Updates
6.7 Square Pharmaceuticals Ltd.
6.6.1 Square Pharmaceuticals Ltd. Corporation Information
6.6.2 Square Pharmaceuticals Ltd. Description and Business Overview
6.6.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
6.7.5 Square Pharmaceuticals Ltd. Recent Developments/Updates
6.8 Incepta Pharmaceuticals Ltd.
6.8.1 Incepta Pharmaceuticals Ltd. Corporation Information
6.8.2 Incepta Pharmaceuticals Ltd. Description and Business Overview
6.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
6.8.5 Incepta Pharmaceuticals Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lurasidone Industry Chain Analysis
7.2 Lurasidone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lurasidone Production Mode & Process
7.4 Lurasidone Sales and Marketing
7.4.1 Lurasidone Sales Channels
7.4.2 Lurasidone Distributors
7.5 Lurasidone Customers
8 Lurasidone Market Dynamics
8.1 Lurasidone Industry Trends
8.2 Lurasidone Market Drivers
8.3 Lurasidone Market Challenges
8.4 Lurasidone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co Ltd
Remedyrepack
Bushu Pharmaceutical, LTD.
Zhejiang Hisun Pharmaceutical Co Ltd
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
List of Tables
    Table 1. Global Lurasidone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Lurasidone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Lurasidone Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Lurasidone Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Lurasidone Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Lurasidone Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Lurasidone Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Lurasidone Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Lurasidone, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Lurasidone, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Lurasidone, Product Type & Application
    Table 12. Global Key Manufacturers of Lurasidone, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Lurasidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lurasidone as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Lurasidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Lurasidone Sales by Region (2019-2024) & (K Units)
    Table 18. Global Lurasidone Sales Market Share by Region (2019-2024)
    Table 19. Global Lurasidone Sales by Region (2025-2030) & (K Units)
    Table 20. Global Lurasidone Sales Market Share by Region (2025-2030)
    Table 21. Global Lurasidone Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Lurasidone Revenue Market Share by Region (2019-2024)
    Table 23. Global Lurasidone Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Lurasidone Revenue Market Share by Region (2025-2030)
    Table 25. North America Lurasidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Lurasidone Sales by Country (2019-2024) & (K Units)
    Table 27. North America Lurasidone Sales by Country (2025-2030) & (K Units)
    Table 28. North America Lurasidone Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Lurasidone Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Lurasidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Lurasidone Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Lurasidone Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Lurasidone Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Lurasidone Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Lurasidone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Lurasidone Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Lurasidone Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Lurasidone Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Lurasidone Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Lurasidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Lurasidone Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Lurasidone Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Lurasidone Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Lurasidone Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Lurasidone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Lurasidone Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Lurasidone Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Lurasidone Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Lurasidone Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Lurasidone Sales (K Units) by Type (2019-2024)
    Table 51. Global Lurasidone Sales (K Units) by Type (2025-2030)
    Table 52. Global Lurasidone Sales Market Share by Type (2019-2024)
    Table 53. Global Lurasidone Sales Market Share by Type (2025-2030)
    Table 54. Global Lurasidone Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Lurasidone Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Lurasidone Revenue Market Share by Type (2019-2024)
    Table 57. Global Lurasidone Revenue Market Share by Type (2025-2030)
    Table 58. Global Lurasidone Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Lurasidone Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Lurasidone Sales (K Units) by Application (2019-2024)
    Table 61. Global Lurasidone Sales (K Units) by Application (2025-2030)
    Table 62. Global Lurasidone Sales Market Share by Application (2019-2024)
    Table 63. Global Lurasidone Sales Market Share by Application (2025-2030)
    Table 64. Global Lurasidone Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Lurasidone Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Lurasidone Revenue Market Share by Application (2019-2024)
    Table 67. Global Lurasidone Revenue Market Share by Application (2025-2030)
    Table 68. Global Lurasidone Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Lurasidone Price (US$/Unit) by Application (2025-2030)
    Table 70. Angelini Holding S.p.A. Corporation Information
    Table 71. Angelini Holding S.p.A. Description and Business Overview
    Table 72. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Angelini Holding S.p.A. Lurasidone Product
    Table 74. Angelini Holding S.p.A. Recent Developments/Updates
    Table 75. Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
    Table 76. Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
    Table 77. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product
    Table 79. Sumitomo Dainippon Pharma Co., Ltd. Recent Developments/Updates
    Table 80. RemedyRepack，Inc. Corporation Information
    Table 81. RemedyRepack，Inc. Description and Business Overview
    Table 82. RemedyRepack，Inc. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. RemedyRepack，Inc. Lurasidone Product
    Table 84. RemedyRepack，Inc. Recent Developments/Updates
    Table 85. Bushu Pharmaceutical, LTD. Corporation Information
    Table 86. Bushu Pharmaceutical, LTD. Description and Business Overview
    Table 87. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Bushu Pharmaceutical, LTD. Lurasidone Product
    Table 89. Bushu Pharmaceutical, LTD. Recent Developments/Updates
    Table 90. Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
    Table 91. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview
    Table 92. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product
    Table 94. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
    Table 95. Healthcare Pharmaceuticals Limited Corporation Information
    Table 96. Healthcare Pharmaceuticals Limited Description and Business Overview
    Table 97. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Healthcare Pharmaceuticals Limited Lurasidone Product
    Table 99. Healthcare Pharmaceuticals Limited Recent Developments/Updates
    Table 100. Square Pharmaceuticals Ltd. Corporation Information
    Table 101. Square Pharmaceuticals Ltd. Description and Business Overview
    Table 102. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Square Pharmaceuticals Ltd. Lurasidone Product
    Table 104. Square Pharmaceuticals Ltd. Recent Developments/Updates
    Table 105. Incepta Pharmaceuticals Ltd. Corporation Information
    Table 106. Incepta Pharmaceuticals Ltd. Description and Business Overview
    Table 107. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Incepta Pharmaceuticals Ltd. Lurasidone Product
    Table 109. Incepta Pharmaceuticals Ltd. Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Lurasidone Distributors List
    Table 113. Lurasidone Customers List
    Table 114. Lurasidone Market Trends
    Table 115. Lurasidone Market Drivers
    Table 116. Lurasidone Market Challenges
    Table 117. Lurasidone Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Lurasidone
    Figure 2. Global Lurasidone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Lurasidone Market Share by Type in 2023 & 2030
    Figure 4. 20mg/tablet Product Picture
    Figure 5. 40mg/tablet Product Picture
    Figure 6. 60mg/tablet Product Picture
    Figure 7. 80mg/tablet Product Picture
    Figure 8. 120mg/tablet Product Picture
    Figure 9. Global Lurasidone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Lurasidone Market Share by Application in 2023 & 2030
    Figure 11. Hospital
    Figure 12. Psychological Clinic
    Figure 13. Others
    Figure 14. Global Lurasidone Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Lurasidone Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Lurasidone Sales (2019-2030) & (K Units)
    Figure 17. Global Lurasidone Average Price (US$/Unit) & (2019-2030)
    Figure 18. Lurasidone Report Years Considered
    Figure 19. Lurasidone Sales Share by Manufacturers in 2023
    Figure 20. Global Lurasidone Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Lurasidone Players: Market Share by Revenue in 2023
    Figure 22. Lurasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Lurasidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Lurasidone Sales Market Share by Country (2019-2030)
    Figure 25. North America Lurasidone Revenue Market Share by Country (2019-2030)
    Figure 26. United States Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Lurasidone Sales Market Share by Country (2019-2030)
    Figure 29. Europe Lurasidone Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Lurasidone Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Lurasidone Revenue Market Share by Region (2019-2030)
    Figure 37. China Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Taiwan Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Lurasidone Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Lurasidone Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Colombia Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Middle East & Africa Lurasidone Sales Market Share by Country (2019-2030)
    Figure 53. Middle East & Africa Lurasidone Revenue Market Share by Country (2019-2030)
    Figure 54. Turkey Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. UAE Lurasidone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Global Sales Market Share of Lurasidone by Type (2019-2030)
    Figure 58. Global Revenue Market Share of Lurasidone by Type (2019-2030)
    Figure 59. Global Lurasidone Price (US$/Unit) by Type (2019-2030)
    Figure 60. Global Sales Market Share of Lurasidone by Application (2019-2030)
    Figure 61. Global Revenue Market Share of Lurasidone by Application (2019-2030)
    Figure 62. Global Lurasidone Price (US$/Unit) by Application (2019-2030)
    Figure 63. Lurasidone Value Chain
    Figure 64. Lurasidone Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions